DANIEL WALKER: Open Payments
NPI 1740615814 · MORTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 10 payments from 7 companies in 2025. Trend: 2023 $202 · 2024 $185 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $69 |
| Novo Nordisk Inc | 2 | $31 |
| Abbott Laboratories | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, CAPLYTA, TRULANCE, JARDIANCE, Rybelsus, QULIPTA.
Industry payments across MS — which companies pay providers there.
